{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T19:42:22Z","timestamp":1776368542400,"version":"3.51.2"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,11,13]],"date-time":"2018-11-13T00:00:00Z","timestamp":1542067200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"DOI":"10.3389\/fcimb.2018.00381","type":"journal-article","created":{"date-parts":[[2018,11,13]],"date-time":"2018-11-13T12:41:24Z","timestamp":1542112884000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Cellular Markers of Active Disease and Cure in Different Forms of Leishmania infantum-Induced Disease"],"prefix":"10.3389","volume":"8","author":[{"given":"Laura","family":"Botana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bel\u00e9n","family":"Mat\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan V.","family":"San Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Romero-Mat\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Ibarra-Meneses","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Aguado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Horrillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Chicharro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Nieto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheila","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Manuel","family":"Ruiz-Giardin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenia","family":"Carrillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2018,11,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e0004468","DOI":"10.1371\/journal.pntd.0004468","article-title":"Successful treatment of human visceral leishmaniasis restores antigen-specific IFN-\u03b3, but not IL-10 production","volume":"10","author":"Adem","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1128\/IAI.68.4.1760-1764.2000","article-title":"Comparison of the immune profile of nonhealing cutaneous Leishmaniasis patients with those with active lesions and those who have recovered from infection","volume":"68","author":"Ajdary","year":"2000","journal-title":"Infect. Immun."},{"key":"B3","doi-asserted-by":"publisher","first-page":"70","DOI":"10.4269\/ajtmh.2012.11-0479","article-title":"Assessment of interferon-\u03b3 levels and leishmanin skin test results in persons recovered for leishmaniasis","volume":"87","author":"Alimohammadian","year":"2012","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"B4","doi-asserted-by":"publisher","first-page":"20546","DOI":"10.2807\/1560-7917.ES2013.18.30.20546","article-title":"Re-emergence of leishmaniasis in Spain: community outbreak in Madrid, Spain, 2009 to 2012","volume":"18","author":"Arce","year":"2013","journal-title":"Euro Surveill."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e0004179","DOI":"10.1371\/journal.pntd.0004179","article-title":"Cytokine release assays as tests for exposure to Leishmania, and for confirming cure from leishmaniasis, in solid organ transplant recipients","volume":"9","author":"Carrillo","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.actatropica.2016.09.026","article-title":"Lymphoproliferative response after stimulation with soluble Leishmania antigen (SLA) as a predictor of visceral leishmaniasis (VL) relapse in HIV+ patients","volume":"164","author":"Castro","year":"2016","journal-title":"Acta Trop."},{"key":"B7","doi-asserted-by":"publisher","first-page":"20545","DOI":"10.2807\/1560-7917.ES2013.18.30.20545","article-title":"Molecular typing of Leishmania infantum isolates from a leishmaniasis outbreak in Madrid, Spain, 2009 to 2012","volume":"18","author":"Chicharro","year":"2013","journal-title":"Euro Surveill."},{"key":"B8","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1006\/cyto.1995.0088","article-title":"In vivo and in vitro cytokine profiles and mononuclear cell subsets in Sicilian patients with active visceral leishmaniasis","volume":"7","author":"Cillari","year":"1995","journal-title":"Cytokine"},{"key":"B9","doi-asserted-by":"publisher","first-page":"S185","DOI":"10.1016\/S0035-9203(02)90074-X","article-title":"A nested polymerase chain reaction (Ln-PCR) for diagnosing and monitoring Leishmania infantum infection in patients co-infected with human immunodeficiency virus","volume":"96","author":"Cruz","year":"2002","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"B10","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.1365-2249.1995.tb03660.x","article-title":"Dichotomy of the T cell response to Leishmania antigens in patients suffering from cutaneous leishmaniasis; absence or scarcity of Th1 activity is associated with severe infections","volume":"100","author":"Gaafar","year":"1995","journal-title":"Clin. Exp. Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"561","DOI":"10.4269\/ajtmh.2004.71.561","article-title":"Elevated plasma levels of interferon (IFN)-gamma, IFN-gamma inducing cytokines, and IFN-gamma inducible CXC chemokines in visceral leishmaniasis","volume":"71","author":"Hailu","year":"2004","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"B12","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.cmi.2014.10.017","article-title":"Atypical presentation in adults in the largest community outbreak of leishmaniasis in Europe (Fuenlabrada, Spain)","volume":"21","author":"Horrillo","year":"2015","journal-title":"Clin. Microbiol. Infect"},{"key":"B13","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3389\/fcimb.2017.00200","article-title":"IFN-\u03b3, IL-2, IP-10, and MIG as biomarkers of exposure to Leishmania spp., and of cure in human visceral leishmaniasis","volume":"7","author":"Ibarra-Meneses","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B14","unstructured":"Localized leishmanial lymphadenopathy: an unusual manifestation of leishmaniasis in a traveler in Southern Europe12131215\n            IgnatiusR.\n            LoddenkemperC.\n            WoitzikJ.\n            SchneiderT.\n            HarmsG.\n          10.1089\/vbz.2011.064221612538Vector Borne Zoonotic Dis.112011"},{"key":"B15","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/icb.1993.64","article-title":"Interferon-gamma and interleukin-4 in human Leishmania donovani infections","volume":"71","author":"Kemp","year":"1993","journal-title":"Immunol. Cell Biol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AAC.04298-14","article-title":"Systematic review of biomarkers to monitor therapeutic response in leishmaniasis","volume":"59","author":"Kip","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e3198","DOI":"10.1371\/journal.pntd.0003198","article-title":"Leishmania specific CD4 T cells release IFN\u03b3 that limits parasite replication in patients with visceral leishmaniasis","volume":"8","author":"Kumar","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1093\/cid\/cit102","article-title":"Increasing failure of miltefosine in the treatment of Kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance","volume":"56","author":"Rijal","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.imbio.2014.01.005","article-title":"Whole blood assay and visceral leishmaniasis: challenges and promises","volume":"219","author":"Singh","year":"2014","journal-title":"Immunobiology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"555","DOI":"10.4321\/S1135-57272012000600002","article-title":"[Review of the current situation and the risk factors of Leishmania infantum in Spain]","volume":"86","author":"Su\u00e1rez Rodr\u00edguez","year":"2012","journal-title":"Rev. Esp. Salud Publica"},{"key":"B21","doi-asserted-by":"publisher","first-page":"822","DOI":"10.4269\/ajtmh.2010.09-0605","article-title":"Quantiferon-Leishmania as an epidemiological tool for evaluating the exposure to Leishmania infection","volume":"83","author":"Turgay","year":"2010","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"B22","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0166-6851(92)90208-2","article-title":"Sequence analysis of small subunit ribosomal RNA genes and its use for detection and identification of Leishmania parasites","volume":"51","author":"van Eys","year":"1992","journal-title":"Mol. Biochem. Parasitol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/1469-0691.12556","article-title":"Leishmaniasis in immunosuppressed individuals","volume":"20","author":"van Griensven","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"B24","volume-title":"Control of the Leishmaniases: Report of a Meeting of the WHO Expert Committee on the Control of Leishmaniases","year":"2010"},{"key":"B25","volume-title":"Manual on Case Management and Surveillance of the Leishmaniases in the WHO European Region","year":"2017"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcimb.2018.00381\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,13]],"date-time":"2018-11-13T12:41:36Z","timestamp":1542112896000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcimb.2018.00381\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,13]]},"references-count":25,"alternative-id":["10.3389\/fcimb.2018.00381"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2018.00381","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,13]]},"article-number":"381"}}